PFIZ34:BVMF
Pfizer BDR
R$40.85
0.00%
(0.00) 1D
Nov 13, 5:54:30 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PFIZ34...
Open
R$40.41
High
R$40.97
Low
R$40.36
Mkt. cap
164.67B
Avg. vol.
9.00K
Volume
738.00
52-wk high
R$42.35
52-wk low
R$29.83
Shares outstanding
5.70B
No. of employees
75K
Open
R$40.41
High
R$40.97
Low
R$40.36
Mkt. cap
164.67B
Avg. vol.
9.00K
Volume
738.00
52-wk high
R$42.35
52-wk low
R$29.83
Shares outstanding
5.70B
No. of employees
75K
News stories
From web sources and news partners
The Motley Fool
·
4 minutes ago
Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy?
TradingView
·
2 hours ago
Pfizer, Inc. Stock 12‑Month Price Target Cut to $29.92, Implies 4% Upside
New Hampshire Union Leader
·
4 hours ago
With $650 million commitment, Pfizer fuels fast business gro...
Yahoo Finance
·
13 hours ago
Top Stock Reports for Visa, ExxonMobil & Pfizer
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer BDR
CEOAlbert Bourla
Employees75K
Founded1849
HeadquartersNew York, New York, United States
Sector-
Industry-
Websitepfizer.com